Passa al contenuto
Merck

Serotonin deficiency alters susceptibility to the long-term consequences of adverse early life experience.

Psychoneuroendocrinology (2015-01-21)
Benjamin D Sachs, Ramona M Rodriguiz, Ha L Tran, Akshita Iyer, William C Wetsel, Marc G Caron
ABSTRACT

Brain 5-HT deficiency has long been implicated in psychiatric disease, but the effects of 5-HT deficiency on stress susceptibility remain largely unknown. Early life stress (ELS) has been suggested to contribute to adult psychopathology, but efforts to study the long-term consequences of ELS have been limited by a lack of appropriate preclinical models. Here, we evaluated the effects of 5-HT deficiency on several long-term cellular, molecular, and behavioral responses of mice to a new model of ELS that combines early-life maternal separation (MS) of pups and postpartum learned helplessness (LH) training in dams. Our data demonstrate that this paradigm (LH/MS) induces depressive-like behavior and impairs pup retrieval in dams. In addition, we show that brain 5-HT deficiency exacerbates anxiety-like behavior induced by LH/MS and blunts the effects of LH/MS on acoustic startle responses in adult offspring. Although the mechanisms underlying these effects remain unclear, following LH/MS, 5-HT-deficient animals had significantly less mRNA expression of the mineralocorticoid receptor in the amygdala than wild-type animals. In addition, 5-HT-deficient mice exhibited reduced mRNA levels of the 5-HT2a receptor and p11 in the hippocampus regardless of stress. LH/MS decreased the number of doublecortin+ immature neurons in the hippocampus in both wild-type (WT) and 5-HT-deficient animals. Our data emphasize the importance of complex interactions between genetic factors and early life experience in mediating long-term changes in emotional behavior. These findings may have important implications for our understanding of the combinatorial roles of 5-HT deficiency, ELS, and postpartum depression in the development of neuropsychiatric disorders.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Saccarosio, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Xileni, histological grade
Sigma-Aldrich
Xileni, ACS reagent, ≥98.5% xylenes + ethylbenzene basis
Sigma-Aldrich
Saccarosio, ≥99.5% (GC)
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Saccarosio, ≥99.5% (GC), BioXtra
Sigma-Aldrich
Saccarosio, BioUltra, Molecular Biology, ≥99.5% (HPLC)
Sigma-Aldrich
Xileni, reagent grade
Supelco
Saccarosio, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Saccarosio, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Saccarosio, ≥99.5% (GC)
Sigma-Aldrich
Saccarosio, ≥99.5% (GC), BioReagent, suitable for cell culture, suitable for insect cell culture
Millipore
Saccarosio, suitable for microbiology, ACS reagent, ≥99.0%
Sigma-Aldrich
Saccarosio, ACS reagent
Sigma-Aldrich
Saccarosio, ≥99.5% (GC), Grade II, suitable for plant cell culture
Sigma-Aldrich
Saccarosio, puriss., meets analytical specification of Ph. Eur., BP, NF
Sigma-Aldrich
Saccarosio, ≥99% (GC), Grade I, suitable for plant cell culture
Sigma-Aldrich
Saccarosio, meets USP testing specifications
Supelco
Saccarosio, analytical standard, for enzymatic assay kit SCA20
Saccarosio, European Pharmacopoeia (EP) Reference Standard